Artificial Intelligence, Open Source, And The Future of Biostatistics

By Jake Gallagher, Worldwide Flex

When it comes to Artificial intelligence (AI) and open-source tools, the real question for clinical research teams isn't whether these tools work; it's how to use them responsibly without compromising accuracy, compliance, or oversight. Here we examine the practical decisions biometrics teams face today: how to validate AI tools using a risk-based approach tied to their specific context of use, how to govern their application through defined approval paths and audit trails, and how to protect patient data when working with AI systems. It also explores how open-source languages are gaining traction alongside established platforms like SAS, supported by frameworks like the R Validation Hub that make regulatory-grade validation achievable. Underpinning all of it are data standards like CDISC, which keep AI-assisted and open-source outputs traceable and reviewable.

If your team is weighing how to integrate these technologies responsibly, this piece offers a clear framework for balancing innovation with the rigor regulated research demands. Understand how validation, governance, and human oversight can work together to help your team move faster without losing the accuracy and accountability your work depends on.